These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 31677236)

  • 1. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
    García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
    J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity.
    Chamberlain K; Riyad JM; Garnett T; Kohlbrenner E; Mookerjee A; Elmastour F; Benard L; Chen J; VandenDriessche T; Chuah MK; Marian AJ; Hajjar RJ; Gurha P; Weber T
    Hum Gene Ther; 2018 Aug; 29(8):927-937. PubMed ID: 29641321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting transgene to the heart and liver with AAV9 by different promoters.
    Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
    Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
    Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
    Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.
    Prasad KM; Smith RS; Xu Y; French BA
    J Gene Med; 2011 Jun; 13(6):333-41. PubMed ID: 21674736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling.
    Konkalmatt PR; Beyers RJ; O'Connor DM; Xu Y; Seaman ME; French BA
    Circ Cardiovasc Imaging; 2013 May; 6(3):478-86. PubMed ID: 23536266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.
    Konkalmatt PR; Wang F; Piras BA; Xu Y; O'Connor DM; Beyers RJ; Epstein FH; Annex BH; Hossack JA; French BA
    J Gene Med; 2012; 14(9-10):609-20. PubMed ID: 23065925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.
    Prasad KM; Xu Y; Yang Z; Acton ST; French BA
    Gene Ther; 2011 Jan; 18(1):43-52. PubMed ID: 20703310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.
    Geisler A; Jungmann A; Kurreck J; Poller W; Katus HA; Vetter R; Fechner H; Müller OJ
    Gene Ther; 2011 Feb; 18(2):199-209. PubMed ID: 21048795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoprecipitate augments the global transduction of the adeno-associated virus serotype 9 after a systemic administration.
    Chai Z; Zhang X; Rigsbee KM; Wang M; Samulski RJ; Li C
    J Control Release; 2018 Sep; 286():415-424. PubMed ID: 30107215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Dexamethasone Administration for Maintaining Global Transduction Efficacy of Adeno-Associated Virus Serotype 9.
    Chai Z; Zhang X; Dobbins AL; Rigsbee KM; Wang B; Samulski RJ; Li C
    Hum Gene Ther; 2019 Jul; 30(7):829-840. PubMed ID: 30700148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase.
    Werfel S; Jungmann A; Lehmann L; Ksienzyk J; Bekeredjian R; Kaya Z; Leuchs B; Nordheim A; Backs J; Engelhardt S; Katus HA; Müller OJ
    Cardiovasc Res; 2014 Oct; 104(1):15-23. PubMed ID: 25082846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer.
    Fang H; Lai NC; Gao MH; Miyanohara A; Roth DM; Tang T; Hammond HK
    Hum Gene Ther Methods; 2012 Aug; 23(4):234-41. PubMed ID: 22966786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Recombinant Adeno-Associated Viral Transduction and Safety Profiles in Cardiomyocytes.
    Ai J; He Y; Zheng M; Wen Y; Zhang H; Huang F; Zhu Y
    Cell Physiol Biochem; 2018; 48(5):1894-1900. PubMed ID: 30092576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle.
    Pacak CA; Suzuki-Hatano S; Khadir F; Daugherty AL; Sriramvenugopal M; Gosiker BJ; Kang PB; Cade WT
    J Transl Med; 2023 Oct; 21(1):748. PubMed ID: 37875924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.
    Pleger ST; Shan C; Ksienzyk J; Bekeredjian R; Boekstegers P; Hinkel R; Schinkel S; Leuchs B; Ludwig J; Qiu G; Weber C; Raake P; Koch WJ; Katus HA; Müller OJ; Most P
    Sci Transl Med; 2011 Jul; 3(92):92ra64. PubMed ID: 21775667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained viral gene delivery from a micro-fibrous, elastomeric cardiac patch to the ischemic rat heart.
    Gu X; Matsumura Y; Tang Y; Roy S; Hoff R; Wang B; Wagner WR
    Biomaterials; 2017 Jul; 133():132-143. PubMed ID: 28433936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.